AVLSA

Atlas Venture Life Science Advisors Portfolio holdings

AUM $662M
This Quarter Return
-38.9%
1 Year Return
+6.63%
3 Year Return
+286.7%
5 Year Return
–
10 Year Return
–
AUM
$522M
AUM Growth
+$522M
Cap. Flow
+$40.4M
Cap. Flow %
7.75%
Top 10 Hldgs %
98.65%
Holding
14
New
1
Increased
1
Reduced
1
Closed
1

Top Buys

1
SION
Sionna Therapeutics, Inc. Common Stock
SION
$38.6M
2
DYN icon
Dyne Therapeutics
DYN
$11.6M

Top Sells

1
IRON icon
Disc Medicine
IRON
$6.21M
2
TECX
Tectonic Therapeutic, Inc. Common Stock
TECX
$3.62M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
KYMR icon
1
Kymera Therapeutics
KYMR
$2.95B
$134M 25.69% 4,896,462 – –
IRON icon
2
Disc Medicine
IRON
$2.07B
$118M 22.69% 2,384,456 -125,000 -5% -$6.21M
DYN icon
3
Dyne Therapeutics
DYN
$1.92B
$95.5M 18.3% 9,130,465 +1,111,111 +14% +$11.6M
DAWN icon
4
Day One Biopharmaceuticals
DAWN
$769M
$51M 9.77% 6,430,257 – –
SION
5
Sionna Therapeutics, Inc. Common Stock
SION
$1.09B
$38.6M 7.41% +3,694,020 New +$38.6M
THRD
6
DELISTED
Third Harmonic Bio
THRD
$36.1M 6.92% 10,402,286 – –
KRRO icon
7
Korro Bio
KRRO
$217M
$19.8M 3.79% 1,137,149 – –
VIGL
8
DELISTED
Vigil Neuroscience
VIGL
$10.4M 1.99% 5,836,874 – –
IMA
9
ImageneBio, Inc. Common Stock
IMA
$150M
$6.42M 1.23% 5,018,178 – –
JBIO
10
Jade Biosciences, Inc. Common Stock
JBIO
$258M
$4.52M 0.87% 1,799,232 – –
QTTB icon
11
Q32 Bio
QTTB
$20.9M
$3.45M 0.66% 2,092,106 – –
GBIO icon
12
Generation Bio
GBIO
$40.4M
$3.35M 0.64% 8,279,484 – –
SPRO icon
13
Spero Therapeutics
SPRO
$116M
$220K 0.04% 305,255 – –
TECX
14
Tectonic Therapeutic, Inc. Common Stock
TECX
$478M
– – -78,447 Closed -$3.62M